<DOC>
	<DOCNO>NCT00411554</DOCNO>
	<brief_summary>The clinical study determines safety efficacy Sitagliptin ( MK0431 ) patient type 2 diabetes mellitus inadequate glycemic control diet/exercise therapy .</brief_summary>
	<brief_title>A Study Sitagliptin Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control Diet/Exercise Therapy ( 0431-054 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Voglibose</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>Patients type 2 diabetes mellitus diet/exercise therapy Patients type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>